Announcement of the results of BoTai Biology's repurchase of company shares through centralized bidding trading, reaching 2% of the total share capital.
Announcement on the progress of Botai Biotechnology's repurchase of company shares by means of centralized bidding trade.
Announcement regarding the adjustment of the repurchase share price limit after the implementation of the annual equity distribution of Biotop in 2023.
Botuo Biotech's 2023 Annual Equity Distribution Implementation Notice
Guotai Junan Securities Co., Ltd. inspection opinions on the differentiated dividends of Hangzhou Botuo Biotechnology Co., Ltd.
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Announcement of Resolutions of Botuo Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Botuo Biotechnology Co., Ltd.
Hangzhou Botuo Biotechnology Co., Ltd. Investor Relations Record Form (2024-003)
Botuo Biotech's announcement on the retirement and resignation of the Deputy General Manager
2023 Annual General Meeting of Shareholders Meeting Materials
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Botuo Biotech's Corrective Notice on the “Notice Concerning the 2023 Profit Distribution Plan”
Botuo Biotech's Notice on Convening the 2023 Annual General Meeting of Shareholders
Botuo Biotech 2024 First Quarter Report
Botuo Biotech's announcement on the use of some idle own funds for cash management
Botuo Biotech's announcement on applying for financing lines from financial institutions in 2024
Botuo Biotech's announcement on holding results briefings for the first quarter of 2023 and 2024
Botuo Biotech's announcement on preparation for asset impairment in 2023
Announcement of Resolutions of the 10th Meeting of the 3rd Board of Supervisors of Botuo Biotech
No Data